Cresco Labs Inc CL
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
-
Cresco Labs Announces Dennis Olis to Retire as Chief Financial Officer
-
Cannabis stocks rally after Trump supports moving drug to less restrictive category
-
Cannabis an 'increasingly bipartisan' issue as Trump signals support: analyst
-
Cannabis stocks drop sharply as DEA sets drug-rescheduling hearing after November election
-
National Leading Vape Brand, Bloom, Partners With Cresco Labs to Launch Products in Florida
-
Cannabis stocks post sharp gains as Trump says he's starting to 'agree more' about reforms
-
Chicago-based cannabis giant Cresco Labs loss widens on $61 million charge for taxes
-
Cresco Labs Reports Consistent Profitability Improvement with Second Quarter 2024 Financial Results
Trading Information
- Previous Close Price
- CAD 2.27
- Day Range
- CAD 2.22–2.31
- 52-Week Range
- CAD 1.45–3.58
- Bid/Ask
- CAD 2.23 / CAD 2.27
- Market Cap
- CAD 775.30 Mil
- Volume/Avg
- 146,083 / 147,033
Key Statistics
- Price/Earnings (Normalized)
- 52.31
- Price/Sales
- 0.75
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
Cresco Labs Inc is a vertically-integrated multi-state cannabis operator in the United States licensed to cultivate, manufacture and sell retail and medical cannabis products through Sunnyside, Cresco Labs’ national dispensary brand and others. The Company operates in one segment, the cultivation, manufacturing, distribution and sale of cannabis.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Value
- Total Number of Employees
- 2,900
- Website
- https://www.crescolabs.com
Comparables
Valuation
|
Metric
|
CL
|
AYR.A
|
OGI
|
|---|---|---|---|
Price/Earnings (Normalized) | 52.31 | 1.49 | — |
Price/Book Value | 1.21 | 0.34 | 0.84 |
Price/Sales | 0.75 | 0.33 | — |
Price/Cash Flow | 6.17 | — | — |
Price/Earnings
CL
AYR.A
OGI
Financial Strength
|
Metric
|
CL
|
AYR.A
|
OGI
|
|---|---|---|---|
Quick Ratio | 1.22 | 0.57 | 2.30 |
Current Ratio | 2.00 | 1.75 | 4.29 |
Interest Coverage | −1.32 | −1.50 | — |
Quick Ratio
CL
AYR.A
OGI
Profitability
|
Metric
|
CL
|
AYR.A
|
OGI
|
|---|---|---|---|
Return on Assets (Normalized) | −3.73% | −7.55% | — |
Return on Equity (Normalized) | −9.99% | −18.32% | — |
Return on Invested Capital (Normalized) | −0.55% | −5.13% | — |
Return on Assets
CL
AYR.A
OGI
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Zoetis Inc Class A
ZTS
| Rspjxtmxn | Bspb | $88.3 Bil | |||
| Merck KGaA ADR
MKKGY
| Yxzwvjkwkf | Bcydhh | $78.0 Bil | |||
| Haleon PLC ADR
HLN
| Dkblfzdqh | Ryplw | $48.4 Bil | |||
| Viatris Inc
VTRS
| Qykjjgprw | Mxx | $13.8 Bil | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| Swxlpsly | Tmjr | $13.5 Bil | |||
| Catalent Inc
CTLT
| Lynczyrwr | Yryzwp | $10.9 Bil | |||
| Prestige Consumer Healthcare Inc
PBH
| Bdthfwf | Nhlxdl | $3.5 Bil | |||
| Perrigo Co PLC
PRGO
| Myvmystc | Ddhg | $3.5 Bil | |||
| Green Thumb Industries Inc
GTBIF
| Yljqtkncgf | Slh | $2.5 Bil | |||
| Curaleaf Holdings Inc
CURLF
| Vqqcvpyj | Qxwv | $2.3 Bil |
United States